Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CYP51A1 | Q16850 | 6/20 | 0.46 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.42 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.41 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL906187 | 1.00 | SMN1; SMN2 (0.53) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| SCHEMBL9629718 | 0.91 | L3MBTL1 (0.51) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| SCHEMBL2012891 | 0.89 | L3MBTL1 (0.50) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| SCHEMBL17607341 | 0.88 | LMNA (0.49) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| SCHEMBL32346286 | 0.85 | LMNA (0.57) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| SCHEMBL21009583 | 0.85 | LMNA (0.57) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| SCHEMBL7952831 | 0.85 | LMNA (0.57) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| SCHEMBL1579049 | 0.85 | LMNA (0.57) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| SCHEMBL10445445 | 0.84 | SMN1; SMN2 (0.50) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 | |
| Hydrochloric Acid SCHEMBL5448253 | 0.83 | LMNA (0.55) | SMN1; SMN2LMNAL3MBTL1GAACYP51A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119355177-B | Detection method and detection kit for multiple tobacco exposure markers in urine | 中国疾病预防控制中心环境与健康相关产品安全所 | 2025-04-08 | — | — | CN | claimed |
| CN-119715877-A | Method for detecting cigarette smoke exposure biomarker based on nanofiber solid phase extraction | 东南大学 | 2025-03-28 | — | — | CN | claimed |
| CN-110462403-B | Diagnostic test for distinguishing smoking status of a subject | 菲利普莫里斯生产公司 | 2024-01-12 | — | — | CN | claimed |
| CN-115326994-A | Method and system for simultaneously analyzing multi-class smoke exposure biomarkers and using method | 上海烟草集团有限责任公司 | 2022-11-11 | — | — | CN | claimed |
| CN-112724757-A | Ionomer coating for eliminating surface charge, preparation method thereof and corresponding coating | 徐宁 | 2021-04-30 | — | — | CN | claimed |
| US-4996324-A | Reacting secondary alcohol with primary alcohol in presence of basic catalyst | BASF AKTIENGESELLSCHAFT (DE) | 1991-02-26 | — | — | US | claimed |
| CN-119846125-A | Method for detecting tobacco-specific N-nitrosamine components in tobacco | 国家烟草质量监督检验中心 | 2025-04-18 | — | — | CN | disclosed |
| CN-119355177-B | Detection method and detection kit for multiple tobacco exposure markers in urine | 中国疾病预防控制中心环境与健康相关产品安全所 | 2025-04-08 | — | — | CN | disclosed |
| CN-119715877-A | Method for detecting cigarette smoke exposure biomarker based on nanofiber solid phase extraction | 东南大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-112353791-B | Slip-derived therapeutic compounds and methods of use thereof | 夸利蒂赫布丘蒂克斯公司 | 2025-02-25 | — | — | CN | disclosed |
| US-20250051746-A1 | METHODS AND COMPOSITIONS FOR REDUCING BACTERIAL LOAD IN TOBACCO | R.J. REYNOLDS TOBACCO COMPANY (US) | 2025-02-13 | — | — | US | disclosed |
| CN-119355177-A | Detection method and detection kit for multiple tobacco exposure markers in urine | 中国疾病预防控制中心环境与健康相关产品安全所 | 2025-01-24 | — | — | CN | disclosed |
| US-12163167-B2 | Methods and compositions for reducing bacterial load in tobacco | R.J. REYNOLDS TOBACCO COMPANY (US) | 2024-12-10 | — | — | US | disclosed |
| US-20130065905-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
| US-20110178151-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW (IL) | 2011-07-21 | — | — | US | disclosed |
| US-20110041859-A1 | Molecularly Imprinted Polymers Selective for Tobacco Specific Nitrosamines and Methods of Using the Same | BRITISH AMERICAN TOBACCO (INVESTMENTS) LIMITED (GB) | 2011-02-24 | — | — | US | disclosed |
| EP-0227057-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ALCANOLS IN 1-POSITION BY AROMATIC OR HETEROCYCLIC GROUPS | BASF Aktiengesellschaft (DE) | 1991-08-21 | — | — | EP | disclosed |
| US-4996324-A | Reacting secondary alcohol with primary alcohol in presence of basic catalyst | BASF AKTIENGESELLSCHAFT (DE) | 1991-02-26 | — | — | US | disclosed |
| EP-0227057-A2 | Process for the preparation of substituted alcanols in 1-position by aromatic or heterocyclic groups | BASF Aktiengesellschaft (DE) | 1987-07-01 | — | — | EP | disclosed |
| US-3969363-A | CARDIOVASCULAR DISORDERS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065905-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE | KYNU, KMO, IDO1 | SMN1; SMN2 4284/4885LMNA 4548/4885L3MBTL1 3419/4885 |
| US-20110178151-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | GPR119, FABP4, LIPC | SMN1; SMN2 3157/4885LMNA 2295/4885L3MBTL1 4450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.